Home > Blogs > Synbio Technologies’ Mammalian Expression Platform: Delivering Premium Recombinant Proteins and Antibodies
Synbio Technologies’ Mammalian Expression Platform: Delivering Premium Recombinant Proteins and Antibodies

Synbio Technologies is one of the leaders in biotechnology, offering advanced services through its mammalian expression platform for recombinant protein and antibody production. The platform provides high-quality products for research, diagnostics, and therapeutic applications, ensuring scalability from milligrams to grams.



Comprehensive Mammalian Expression Services

Synbio Technologies’ mammalian expression system supports both high-throughput recombinant antibody production and large-scale protein production. This service allows for efficient generation of antibodies ideal for research and clinical uses. Additionally, Synbio Technologies produces recombinant proteins at varying scales, from milligrams to grams, providing flexibility for diverse client needs. The platform ensures consistent, high-yield results, making it valuable for industries requiring reliable protein and antibody production.

 

High-Quality Standards and Quality Control

Synbio Technologies maintains rigorous quality standards for its mammalian expression platform. The produced proteins and antibodies meet ≥98% purity, ensuring high precision for critical applications. Furthermore, endotoxin levels are controlled to remain below 0.001 EU/μg, making Synbio Technologies’ products safe for use in drug discovery and clinical trials.

 

Versatility and Applications of Mammalian Expression

Synbio Technologies’ mammalian expression platform is versatile, supporting industries such as pharmaceuticals, biotechnology, and research. It is particularly beneficial for drug discovery, immunotherapy, and diagnostic development. The high-throughput antibody production service ensures that antibodies are both specific and potent, making them suitable for clinical trials and larger-scale studies.

 

Conclusion

Synbio Technologies’ mammalian expression platform is an innovative solution for producing high-quality recombinant proteins and antibodies. With its broad range of services and strict quality control, Synbio Technologies provides reliable products that support research, drug development, and therapeutic applications. Synbio Technologies remains a trusted partner in advancing biotechnology with state-of-the-art mammalian expression technologies.

  • Address:
    9 Deer Park Dr., Suite J-25
    Monmouth Junction, NJ 08852

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
To find out more about the cookies we use, see our Privacy Policy.

Accept